The global burn care market size was estimated at USD 2.60 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.18% from 2024 to 2030. The demand for burn care products is rising due to the rising incidence of burns, high demand for skin grafts, growing awareness regarding treatment options, and increasing technological advancements. Increasing awareness among people regarding various treatment options related to burn care is a crucial factor driving the market over the forecast period. The market is also gaining pace owing to rising willingness among people to spend more and opt for new advanced burn care products.
The demand for burn care products used in home settings has eventually increased to avoid visiting healthcare facilities, especially in the post-pandemic era. In addition, many patients adopted online counseling for their health-related concerns. Key players are launching products to provide online counseling and guidance to patients who cannot visit healthcare facilities for treatment. For instance, in April 2020, Healogics, Inc. launched the Healogics Telehealth Program for wound care patients during the COVID-19 crisis, and it was available to provide patients access to continuous wound care and various options for wound care treatments to help limit the potential need for hospitalization or emergency room admission. Some wound care centers are engaged in supporting hospitals with COVID-19 treatment. Therefore, this program allows patients at these centers to receive continuous wound care.
In addition, many doctors and clinicians also use telehealth to treat their patients and provide knowledge regarding using advanced wound care products. The following are the latest insights published on MobiHealthNews (HIMSS) in December 2021: VeCare, a point-of-care wound evaluation platform developed by researchers from the National University of Singapore, consists of a smart wearable with sensors that can conduct a real-time, point-of-care evaluation of chronic wounds wirelessly through an application. This wearable device can detect factors of chronic wounds within 15 minutes. Such factors are further contributing to market growth.
Favorable government plans such as reimbursement policies, which cover almost 70.00-100.00% of the treatment cost, urge the patients to choose advanced burn care treatment. The presence of government and non-profit organizations, such as the World Health Organization (WHO) and the American Burn Association (ABA), respectively, also contribute to increasing awareness levels. The WHO has been collaboratively working with The International Society for Burn Injuries and other such organizations to develop strategies to improve burn care and prevent burn injuries globally.
Skin grafts are majorly used on full-thickness & partial burns and are essential in treating injuries. Skin grafts can be biological or synthetic. Owing to this trend, the demand for skin grafts and other skin substitutes in treating and managing acute burns has increased and is rising constantly. In addition, key players operating in the burn care market focus on planned initiatives like launching new products, and mergers and acquisitions are helping the market’s growth. For instance, in January 2023, Convatec Group PLC introduced Convafoam, an advanced foam dressing in the U.S. The product is designed to fulfill the needs of patients and healthcare providers. It can be used for various types of wounds at any stage of the wound, which makes it the simple dressing choice for skin protection and wound management.
The burn care sector is driven by continuous technological advancements and innovations, focusing on product enhancement and development to meet the evolving market demands. The growth of advanced wound care therapeutics utilizing ex vivo models provides strong, reproducible data to support clinical trials. As a result, market players are investing in innovative technologies and procedures to keep up with the demand.
Several market players such as Smith & Nephew, 3M, Cardinal Health, Hollister Incorporated, Integra LifeSciences Corporation, DeRoyal Industries, Inc., Coloplast Corp., ConvaTec Inc., Mölnlycke Health Care AB and Johnson & Johnson and others, indicate a concerted effort towards strategic collaborations and geographical expansion to address the growing demand and capitalize on market opportunities.
Regulatory standards, such as FDA (Food and Drug Administration) approvals in the U.S. or CE marking in the European Union, are essential, demanding comprehensive preclinical and clinical assessments, stringent manufacturing practices, and documentation to gain market approval.
The burn care market expansion is driven by the growth of innovative burn wound care therapeutics, utilizing ex vivo models to provide strong, reproducible data to support clinical trials and innovative treatment using tilapia skin as a xenograft. This product expansion is anticipated to continue, benefiting patients, surgeons, and healthcare providers.
The advanced dressing segment dominated the market and accounted for the largest revenue share of 42.54% in 2023, owing to the wide product range and extensive application in wound management. Advanced wound dressings include collagen, alginate, hydrocolloid, hydrogel dressings, foam, and film dressings, as well as other advanced dressing products. In addition, the development of advanced products such as ConvaTec’s FoamLite foam dressing, which can be used for a range of low to heavy exuding wounds, is further contributing to segment growth.
The biologics segment is anticipated to witness the fastest growth over the forecast period owing to introduction of new products and extensive R&D in this field. Biologics involve the application of active biological agents and molecules, such as monoterpenes (sulbogin, thymol, and sericin) that are antioxidants, antimicrobials, and anti-inflammatory in nature. Biologic dressings also include skin grafts (allografts, xenografts, autografts, or cadaveric human skin) and tissue-engineered products designed to replace the function and form of skin, either temporarily or permanently. The ready availability of skin from patients in case of biologic skin dressings or skin grafts is the major advantage of skin grafts.
The full-thickness burns segment dominated the burn care market in 2023. According to a WHO report (published in October 2023), approximately 1,80,000 deaths are caused by burns every year. Moreover, rising number of government and nongovernment organizations for burn care treatment is driving the market.
Chronic wounds include partial thickness and full thickness burns. These conditions take longer to heal and cover more than 15.0% of the body. The partial thickness burn segment is expected to exhibit the fastest growth over the forecast period. According to the U.S. FDA, approximately 40,000 people are hospitalized each year due to partial burns. The demand and usage of biologics such as skin grafts and advanced dressings for treatment of partial burns is increasing, thereby boosting the growth of this segment.
The minor burn segment is expected to grow significantly over the forecast period. According to the National Center for Injury Prevention and Control, 1.2 million people in the U.S. are affected by burn injuries annually. The minor burns market is expected to grow steadily over the forecast period. Treatment of minor burns includes traditional care products such as gauze, tapes, and bandages. Advanced dressings are seldom used for treating minor burns.
The thermal burns segment accounted for the largest revenue share in 2023 owing to a high incidence of fire-related burn injuries. According to the American Burn Association (ABA), fire burns are responsible for 44.0% of burn center burn admissions. Scalding is caused by hot liquids or gases and most commonly occurs from exposure to high-temperature tap water while taking baths, hot cooking oil, steam, and hot drinks. Children are particularly at risk of accidental burns.
The chemical burns segment is anticipated to witness the fastest growth over the forecast period. Chemical burns occur when the skin encounters chemicals or their fumes and corrosive products, most probably acids. Chemicals or fumes diffuse into the skin and damage the underlying tissue without causing any apparent damage to the surface. Chemical burns occur immediately on contact. Prolonged exposure severely damages human tissues and leads to scarring. Acids damage cells by coagulating them, while bases liquefy cells. Alkalis cause more injury than acids and bases as they react with the lipids within the body.
The hospitals segment accounted for the largest revenue share in 2023, owing to the increasing incidence of burns and hospitalizations each year. According to the article published by the American Burn Association in January 2020, over 450,000 people are affected by burn injuries every year in the U.S. Hospitals provide an extensive array of treatment options about burn care and follow 504 DRG to provide quick reimbursements for burn-affected patients from the Medicare program. It also offers advanced burn care products, which contribute to the overall growth of the hospital segment. These factors are responsible for the segment growth.
The outpatient facilities segment is anticipated to be the fastest-growing segment over the forecast period. This includes all the facilities where care is provided at standalone establishments outside hospitals. These facilities are designed to provide specialized burn care services on an outpatient basis, meaning patients can receive treatment and care without staying in the hospital. Outpatient burn care facilities may provide various services, including wound care, pain management, rehabilitation, and counseling. Government initiatives to improve healthcare expenditure and infrastructure are also aiding in segment's growth.
North America dominated the market and accounted for the largest revenue share of 51.56% in 2023, owing to the increasing incidence of burns. According to a report by the American Burn Association, in 2018, over 300 children were treated in emergency rooms in the U.S. each day, with two children dying from burn injuries. In the U.S., children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Therefore, burn care products are anticipated to be in high demand because of the high rate of burns.
The U.S. is the largest market due to a high incidence of burns. As per a report by WHO published in October 2023, South Africa spent USD 26 million annually for care of burns from kerosene (paraffin) cookstove incidents. Moreover, presence of nonprofit organizations, such as American Burn Association, which are dedicated to improving the lives of those affected by burns, is expected to fuel growth of the U.S. market.
In Asia Pacific, the market is projected to witness the fastest CAGR over the forecast period. According to the WHO, the incidence of burn injuries that require immediate medical attention is approximately 20 times higher in the Western Pacific Region in comparison with the Americas. Moreover, each year, approximately 50,000 burns-related hospital admissions are recorded in Australia, with young children being particularly vulnerable. Scald burns (65%) and flame burns (20%) are the most common burn-related injuries among children aged four and under. Thus, an increase in the incidence of burn injuries is a significant factor boosting the market in this region.
China accounted for the Asia Pacific's largest share in 2023, owing to the increase in burn injuries and economic development. Furthermore, increasing R&D in advanced wound care is expected to boost the market over the forecast period. Favorable healthcare policies and presence of government organizations are driving market growth. These factors are expected to result in high market growth over the forecast period.
Smith & Nephew plc, 3M, ConvaTec Inc., Hollister Incorporated, Johnson and Johnson (DePuy Synthes, Inc.), Mölnlycke Health Care AB are some of the dominant players operating in market.
3M develops, manufactures, & markets a range of products and services globally. The company functions across four reportable segments: transportation & electronics, safety & industrial, healthcare, and consumer goods.
Smith & Nephew is a medical technology company engaged in developing, manufacturing, marketing, and selling medical services & devices. The company provides services in orthopedics, sports medicine & ENT, and advanced wound care management.
Hollister Incorporated is a developer, manufacturer, and provider of healthcare products. The company offers wound care products, oral endotracheal tube fasteners, and tube attachment devices.
Molnlycke Health Care and Johnson & Johnson are some emerging market players functioning in the industry.
Molnlycke Health Care manufactures single-use surgical and wound care products intended to serve the healthcare sector.
In March 2023, Convatec received FDA clearance for its device designed to manage complex surgical wounds and burns. InnovaBurn placental extracellular matrix medical device will serve as advanced ECM technology for partial-thickness, second-degree burns.
In January 2023, Convatec Group PLC launched Convafoam, an advanced foam dressing in the U.S. The product is designed to fulfill the needs of patients and healthcare providers. It can be used for various types of wounds at any stage of the wound, which makes it the simple dressing choice for skin protection and wound management.
In December 2022, MediWound received FDA clearance for its NexoBrid. It is used for the treatment of severe thermal burns in adults.
In June 2022, Smith & Nephew PLC announced the construction of a new manufacturing and R&D facility for its Advanced Wound Management in the UK. The company is also planning to invest over USD 100 Million to develop modern R&D, manufacturing & flexible office environment in the country.
Report Attribute |
Details |
Market size value in 2024 |
USD 2.78 billion |
Revenue forecast in 2030 |
USD 4.22 billion |
Growth rate |
CAGR of 7.18% from 2024 to 2030 |
Base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
January 2024 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Product, depth of burn, cause, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
3M; Hollister Incorporated; Cardinal Health; Integra LifeSciences Corporation; Coloplast Corp.; DeRoyal Industries, Inc.; Smith & Nephew; ConvaTec Inc.; Mölnlycke Health Care AB; Johnson & Johnson |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global burn care market report based on product, depth of burn, cause, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced dressing
Alginate Dressing
Collagen Dressing
Hydrogel Dressing
Hydrocolloid Dressings
Wound Contact Layers
Film Dressings
Foam Dressings
Others
Biologics
Traditional burn care products
Others
Depth of Burn Outlook (Revenue, USD Million, 2018 - 2030)
Minor burns
Partial thickness burns
Full thickness burns
Cause Outlook (Revenue, USD Million, 2018 - 2030)
Thermal Burns
Electrical Burns
Radiation Burns
Chemical Burns
Friction Burns
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Research & Manufacturing
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global burn care market size was estimated at USD 2.60 billion in 2023 and is expected to reach USD 2.78 billion in 2024.
b. The global burn care market is expected to grow at a compound annual growth rate of 7.18% from 2024 to 2030 to reach USD 4.22 billion by 2030.
b. Thermal burns held the largest share of the burn care market in 2023 with a market share of more than 74.5% owing to a rising incidence of fire-related burn injuries.
b. Some key players operating in the burn care market include Smith & Nephew, Johnson & Johnson, ConvaTec Inc., Mölnlycke Health Care AB, and 3M.
b. Key factors that are driving the burn care market growth include rising demand for minimally invasive procedures to improve cosmetic appeal for patients suffering from burns.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."